SLE (n=26)* | APS (n=32)* | Thrombophilia (n=35) | |
---|---|---|---|
Patients treated with LMWH, n* | 2 | 2 | 23 |
Patients treated with ASA, n* | 9 | 1 | 3 |
Patients treated with LMWH + ASA, n* | 5 | 29 | 8 |
Patients without prophylactic treatment, n | 10 | 0 | 1 |
*Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Low-Molecular-Weight Heparin (LMWH), Acetylsalicylic Acid (ASA).